Uveitis
MONDO:0020283An inflammatory process affecting a part of or the entire uvea. Causes include inflammatory agents (e.g., herpes simplex, herpes zoster, leptospirosis) and systemic diseases (e.g., inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, ankylosing spondylitis). Patients present with pain and redness in the eye, light sensitivity, and blurred and decreased vision.
Also known as: inflammation of uvea, uvea inflammation, uveitis, uveitis (disease)
67 clinical trials for this condition and its sub-types, 37 tagged with Uveitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Uveitis
-
Posterior uveitis 10 trials · 22 incl. sub-types
3 sub-types
- Retinitis 1 trial · 10 incl. sub-types Sub-types →
- Birdshot chorioretinopathy 2 trials
- Choroiditis 0 trials · 1 incl. sub-types Sub-types →
-
Anterior uveitis 8 trials · 20 incl. sub-types
3 sub-types
- Non-infectious anterior uveitis 7 trials Sub-types →
- Iridocyclitis 1 trial · 6 incl. sub-types Sub-types →
- Idiopathic anterior uveitis 0 trials
-
Panuveitis 6 trials · 9 incl. sub-types
4 sub-types
- Vogt-Koyanagi-Harada disease 2 trials
- Infectious panuveitis 1 trial
- Idiopathic panuveitis 0 trials Sub-types →
- Sympathetic ophthalmia 0 trials
-
Intermediate uveitis 8 trials
2 sub-types
- Hyalitis 0 trials
- Pars planitis 0 trials
-
Iritis 0 trials · 6 incl. sub-types
1 sub-type
- Iridocyclitis 1 trial · 6 incl. sub-types Sub-types →
-
Autoimmune uveitis 2 trials
-
Chorioretinitis 2 trials
4 sub-types
- Disseminated chorioretinitis 0 trials
- Focal chorioretinitis 0 trials Sub-types →
- Microcephaly and chorioretinopathy 0 trials Sub-types →
- Pars planitis 0 trials
-
Idiopathic posterior uveitis 1 trial
-
Suppurative uveitis 0 trials
Most studied deeper sub-types
-
Experimental antibody takes aim at eye inflammation
Disease control Stopped earlyThis study tests an experimental drug called REGN7041 in 72 people with active noninfectious uveitis, a condition causing inflammation inside the eye. The drug is an antibody designed to calm the immune system. Since this is the first time it's tested in humans, the main goal is …
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
COVID-19 vaccine response under scrutiny in autoimmune patients
Knowledge-focused Stopped earlyThis study looked at how well the COVID-19 vaccine triggers an immune response in people with autoimmune or inflammatory diseases who take immunosuppressants or biologics. Researchers took blood samples before vaccination and at several points after to measure antibodies and T-ce…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:24 UTC